-

Five Leading Real-World Data and Analytics Organizations Join the RWE Alliance, Doubling Membership

WASHINGTON--(BUSINESS WIRE)--The RWE Alliance is pleased to announce the addition of five new members—ConcertAI, OM1, Syneos Health, Verana Health, and Verily—to continue to advance policies to support regulatory use of real-world evidence (RWE). The RWE Alliance is a policy and advocacy coalition of real-world data (RWD) and analytics organizations with a common interest in harnessing the power of RWE to inform regulatory decision making to improve patients’ lives. The founding members of the Alliance are Aetion, Flatiron Health, IQVIA, Syapse, and Tempus.

Since the Alliance launched in May 2021, regulators and policymakers have continued to recognize the need for new policies to help advance innovations to realize the full potential of data to benefit patients. As FDA refines new RWD/E draft guidance documents, the Administration relaunches the Cancer Moonshot, and congressional policymakers consider bipartisan health legislation such as the FDA user fee reauthorization, PREVENT Pandemics Act, and Cures 2.0, among other policy developments, the value of a unified, expert voice on RWE policy becomes increasingly clear.

The Alliance’s founding members are thrilled to welcome the new member organizations to the coalition and look forward to joining together to advance the use of RWE to support regulatory decisions and benefit patients.

The Alliance is supported by Covington & Burling LLP.

About RWE Alliance

We are a coalition of real-world data (RWD) and analytics organizations with a common interest in harnessing the power of real-world evidence (RWE) to inform regulatory decision making to improve patients’ lives. Our members have deep knowledge and experience working with healthcare data across disease areas and patient populations, and we aim to bring these collective insights to bear in support of RWE policies.

https://rwealliance.org/

Contacts

Morgan Schreurs
info@rwealliance.org

Industry:

RWE Alliance

Release Versions
English

Contacts

Morgan Schreurs
info@rwealliance.org

More News From RWE Alliance

RWE Alliance Submits Comments on All Four Recent FDA RWE Guidances, Looks Toward Further Engagement to Advance Use of RWE to Benefit Patients

WASHINGTON--(BUSINESS WIRE)--Today, the RWE Alliance submitted a substantial comment letter in response to the U.S. Food and Drug Administration’s (FDA) recent draft guidance, “Considerations for the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products.” The RWE Alliance commends the Agency for recently issuing four substantive draft guidances on key real-world data and evidence (RWD/E) topics as part of the Agency’s RWE Program,...

RWE Alliance Submits Comments on FDA’s RWE Draft Guidance, Highlights Recommendations for Agency’s RWE Program and RWE Derived from EHR/Claims Data

WASHINGTON--(BUSINESS WIRE)--Today, the RWE Alliance submitted a substantial comment letter in response to the U.S. Food and Drug Administration (FDA) draft guidance on using electronic health records (EHRs) and medical claims data to support regulatory decision making across therapeutic areas. The RWE Alliance commends the Agency for providing this draft guidance. The RWE Alliance is committed to identifying methods that can enhance confidence in RWE study results and facilitate the integratio...

RWE Alliance Supports Califf Nomination, Urges Continued Focus at FDA on Advancing Use of Real-World Evidence to Benefit Patients

WASHINGTON--(BUSINESS WIRE)--The RWE Alliance supports the nomination of Dr. Robert Califf to serve as Commissioner of the U.S. Food and Drug Administration (FDA). As a former FDA Commissioner and the founder of the Duke Clinical Research Institute, Dr. Califf is a leader in advancing innovative clinical trial designs and the use of real-world data and evidence to inform regulatory decision making. It is crucial to have an FDA Commissioner that understands the role real-world data and evidence...
Back to Newsroom